Analysts Expect U.S. Physical Therapy, Inc. (NYSE:USPH) Will Announce Quarterly Sales of $123.07 Million

Equities analysts forecast that U.S. Physical Therapy, Inc. (NYSE:USPH) will post $123.07 million in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for U.S. Physical Therapy’s earnings, with estimates ranging from $119.13 million to $125.10 million. U.S. Physical Therapy posted sales of $83.86 million during the same quarter last year, which would indicate a positive year over year growth rate of 46.8%. The company is expected to report its next quarterly earnings report on Thursday, August 5th.

According to Zacks, analysts expect that U.S. Physical Therapy will report full year sales of $482.35 million for the current year, with estimates ranging from $470.25 million to $488.40 million. For the next fiscal year, analysts anticipate that the business will post sales of $511.03 million, with estimates ranging from $501.94 million to $519.60 million. Zacks’ sales calculations are an average based on a survey of research analysts that that provide coverage for U.S. Physical Therapy.

U.S. Physical Therapy (NYSE:USPH) last posted its quarterly earnings data on Thursday, May 6th. The company reported $0.64 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.47 by $0.17. U.S. Physical Therapy had a return on equity of 14.19% and a net margin of 7.73%. The firm had revenue of $112.37 million during the quarter, compared to analysts’ expectations of $110.36 million. During the same quarter last year, the firm earned $0.30 EPS. The business’s quarterly revenue was down .3% on a year-over-year basis.

A number of analysts have commented on USPH shares. Barrington Research raised U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $130.00 price target for the company in a research report on Friday, May 7th. Zacks Investment Research upgraded shares of U.S. Physical Therapy from a “sell” rating to a “hold” rating in a report on Thursday, May 13th. Finally, Jefferies Financial Group upgraded shares of U.S. Physical Therapy from a “hold” rating to a “buy” rating and lifted their price objective for the company from $130.00 to $135.00 in a research note on Monday, May 3rd.

In other news, COO Graham D. Reeve sold 1,819 shares of the business’s stock in a transaction that occurred on Friday, May 7th. The stock was sold at an average price of $117.99, for a total value of $214,623.81. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Edward L. Kuntz sold 1,600 shares of the stock in a transaction that occurred on Monday, March 15th. The shares were sold at an average price of $121.73, for a total value of $194,768.00. The disclosure for this sale can be found here. Over the last quarter, insiders sold 9,669 shares of company stock valued at $1,158,022. Company insiders own 1.80% of the company’s stock.

A number of institutional investors and hedge funds have recently made changes to their positions in the business. ProShare Advisors LLC purchased a new stake in shares of U.S. Physical Therapy in the fourth quarter valued at approximately $367,000. Wasatch Advisors Inc. grew its holdings in U.S. Physical Therapy by 51.3% in the 1st quarter. Wasatch Advisors Inc. now owns 258,037 shares of the company’s stock valued at $26,862,000 after buying an additional 87,462 shares in the last quarter. Engineers Gate Manager LP acquired a new stake in shares of U.S. Physical Therapy in the 4th quarter worth $889,000. Truist Financial Corp increased its stake in shares of U.S. Physical Therapy by 19.0% in the 4th quarter. Truist Financial Corp now owns 10,082 shares of the company’s stock worth $1,213,000 after acquiring an additional 1,612 shares during the last quarter. Finally, Lazard Asset Management LLC acquired a new position in shares of U.S. Physical Therapy during the 4th quarter valued at about $1,500,000. 97.78% of the stock is currently owned by institutional investors.

Shares of USPH stock traded down $0.77 during trading hours on Monday, reaching $118.98. 235 shares of the company’s stock were exchanged, compared to its average volume of 68,144. U.S. Physical Therapy has a 1 year low of $70.97 and a 1 year high of $143.67. The company has a debt-to-equity ratio of 0.06, a quick ratio of 0.83 and a current ratio of 0.83. The stock has a market cap of $1.53 billion, a PE ratio of 48.09 and a beta of 1.46. The firm has a fifty day moving average price of $114.30.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 11th. Stockholders of record on Friday, May 14th will be paid a dividend of $0.35 per share. The ex-dividend date of this dividend is Thursday, May 13th. This represents a $1.40 dividend on an annualized basis and a dividend yield of 1.18%. U.S. Physical Therapy’s payout ratio is 46.82%.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Further Reading: Insider Trading – What You Need to Know

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit

Earnings History and Estimates for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with's FREE daily email newsletter.